Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Mar 1;101(5):956–960. doi: 10.1172/JCI1144

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

E Tahvanainen 1, M Syvanne 1, M H Frick 1, S Murtomaki-Repo 1, M Antikainen 1, Y A Kesaniemi 1, H Kauma 1, A Pasternak 1, M R Taskinen 1, C Ehnholm 1
PMCID: PMC508645  PMID: 9486964

Abstract

The associations between six genetic polymorphisms in the hepatic lipase (HL) gene (LIPC) and variation in postheparin HL activity and fasting serum lipoproteins were evaluated in 395 male Finnish coronary heart disease patients with HDL cholesterol concentrations </= 1.1 mmol/liter. The LIPC promoter polymorphism at position -514 was highly significantly associated with variation in HL activity (P = 0.0000008), with mean activities of 20.4, 17.5, and 13.2 mumol free fatty acid/ml per hour in subjects having C/C, C/T, and T/T genotypes, respectively. Furthermore, the triglyceride content of low density lipoprotein, intermediate density lipoprotein and HDL, and the cholesterol content of intermediate density lipoprotein were found to be associated with variation at LIPC position -514. However, there was no association of this polymorphism with coronary heart disease. These data suggest that the LIPC promoter variation is likely to be the basis for variation in HL activity, which underlies the variation in serum lipoprotein phenotypes in this sample.

Full Text

The Full Text of this article is available as a PDF (210.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ameis D., Stahnke G., Kobayashi J., McLean J., Lee G., Büscher M., Schotz M. C., Will H. Isolation and characterization of the human hepatic lipase gene. J Biol Chem. 1990 Apr 25;265(12):6552–6555. [PubMed] [Google Scholar]
  2. Auwerx J. H., Babirak S. P., Hokanson J. E., Stahnke G., Will H., Deeb S. S., Brunzell J. D. Coexistence of abnormalities of hepatic lipase and lipoprotein lipase in a large family. Am J Hum Genet. 1990 Mar;46(3):470–477. [PMC free article] [PubMed] [Google Scholar]
  3. Blades B., Vega G. L., Grundy S. M. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb. 1993 Aug;13(8):1227–1235. doi: 10.1161/01.atv.13.8.1227. [DOI] [PubMed] [Google Scholar]
  4. Brand K., Dugi K. A., Brunzell J. D., Nevin D. N., Santamarina-Fojo S. A novel A-->G mutation in intron I of the hepatic lipase gene leads to alternative splicing resulting in enzyme deficiency. J Lipid Res. 1996 Jun;37(6):1213–1223. [PubMed] [Google Scholar]
  5. Breckenridge W. C., Little J. A., Alaupovic P., Wang C. S., Kuksis A., Kakis G., Lindgren F., Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 1982 Nov;45(2):161–179. doi: 10.1016/0021-9150(82)90136-8. [DOI] [PubMed] [Google Scholar]
  6. Busch S. J., Barnhart R. L., Martin G. A., Fitzgerald M. C., Yates M. T., Mao S. J., Thomas C. E., Jackson R. L. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J Biol Chem. 1994 Jun 10;269(23):16376–16382. [PubMed] [Google Scholar]
  7. Cai S. J., Wong D. M., Chen S. H., Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry. 1989 Nov 14;28(23):8966–8971. doi: 10.1021/bi00449a002. [DOI] [PubMed] [Google Scholar]
  8. Cohen J. C., Wang Z., Grundy S. M., Stoesz M. R., Guerra R. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest. 1994 Dec;94(6):2377–2384. doi: 10.1172/JCI117603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Connelly P. W., Maguire G. F., Lee M., Little J. A. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis. 1990 Jan-Feb;10(1):40–48. doi: 10.1161/01.atv.10.1.40. [DOI] [PubMed] [Google Scholar]
  10. Dugi K. A., Feuerstein I. M., Hill S., Shih J., Santamarina-Fojo S., Brewer H. B., Jr, Hoeg J. M. Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):354–364. doi: 10.1161/01.atv.17.2.354. [DOI] [PubMed] [Google Scholar]
  11. Ehnholm C., Kuusi T. Preparation, characterization, and measurement of hepatic lipase. Methods Enzymol. 1986;129:716–738. doi: 10.1016/0076-6879(86)29101-6. [DOI] [PubMed] [Google Scholar]
  12. Ehnholm C., Shaw W., Greten H., Brown W. V. Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids. J Biol Chem. 1975 Sep 10;250(17):6756–6761. [PubMed] [Google Scholar]
  13. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  14. Groener J. E., Pelton R. W., Kostner G. M. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem. 1986 Feb;32(2):283–286. [PubMed] [Google Scholar]
  15. Guerra R., Wang J., Grundy S. M., Cohen J. C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4532–4537. doi: 10.1073/pnas.94.9.4532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Guo S. W., Thompson E. A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 1992 Jun;48(2):361–372. [PubMed] [Google Scholar]
  17. Hadzopoulou-Cladaras M., Cardot P. Identification of a cis-acting negative DNA element which modulates human hepatic triglyceride lipase gene expression. Biochemistry. 1993 Sep 21;32(37):9657–9667. doi: 10.1021/bi00088a018. [DOI] [PubMed] [Google Scholar]
  18. Hegele R. A., Little J. A., Connelly P. W. Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochem Biophys Res Commun. 1991 Aug 30;179(1):78–84. doi: 10.1016/0006-291x(91)91336-b. [DOI] [PubMed] [Google Scholar]
  19. Hegele R. A., Little J. A., Vezina C., Maguire G. F., Tu L., Wolever T. S., Jenkins D. J., Connelly P. W. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb. 1993 May;13(5):720–728. doi: 10.1161/01.atv.13.5.720. [DOI] [PubMed] [Google Scholar]
  20. Hegele R. A., Tu L., Connelly P. W. Human hepatic lipase mutations and polymorphisms. Hum Mutat. 1992;1(4):320–324. doi: 10.1002/humu.1380010410. [DOI] [PubMed] [Google Scholar]
  21. Huttunen J. K., Ehnholm C., Kinnunen P. K., Nikkilä E. A. An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta. 1975 Sep 16;63(3):335–347. doi: 10.1016/0009-8981(75)90055-8. [DOI] [PubMed] [Google Scholar]
  22. Katzel L. I., Coon P. J., Busby M. J., Gottlieb S. O., Krauss R. M., Goldberg A. P. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb. 1992 Jul;12(7):814–823. doi: 10.1161/01.atv.12.7.814. [DOI] [PubMed] [Google Scholar]
  23. Knudsen P., Antikainen M., Ehnholm S., Uusi-Oukari M., Tenkanen H., Lahdenperä S., Kahri J., Tilly-Kiesi M., Bensadoun A., Taskinen M. R. A compound heterozygote for hepatic lipase gene mutations Leu334-->Phe and Thr383-->Met: correlation between hepatic lipase activity and phenotypic expression. J Lipid Res. 1996 Apr;37(4):825–834. [PubMed] [Google Scholar]
  24. Knudsen P., Antikainen M., Uusi-Oukari M., Ehnholm S., Lahdenperä S., Bensadoun A., Funke H., Wiebusch H., Assmann G., Taskinen M. R. Heterozygous hepatic lipase deficiency, due to two missense mutations R186H and L334F, in the HL gene. Atherosclerosis. 1997 Feb 10;128(2):165–174. doi: 10.1016/s0021-9150(96)05999-0. [DOI] [PubMed] [Google Scholar]
  25. Kounnas M. Z., Chappell D. A., Wong H., Argraves W. S., Strickland D. K. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J Biol Chem. 1995 Apr 21;270(16):9307–9312. doi: 10.1074/jbc.270.16.9307. [DOI] [PubMed] [Google Scholar]
  26. Kuusi T., Ehnholm C., Viikari J., Härkönen R., Vartiainen E., Puska P., Taskinen M. R. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res. 1989 Aug;30(8):1117–1126. [PubMed] [Google Scholar]
  27. MacLean C. J., Morton N. E. Estimation of myriad haplotype frequencies. Genet Epidemiol. 1985;2(3):263–272. doi: 10.1002/gepi.1370020304. [DOI] [PubMed] [Google Scholar]
  28. Miller G. J., Miller N. E. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975 Jan 4;1(7897):16–19. doi: 10.1016/s0140-6736(75)92376-4. [DOI] [PubMed] [Google Scholar]
  29. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mori A., Takagi A., Ikeda Y., Ashida Y., Yamamoto A. An AvaII polymorphism in exon 5 of the human hepatic triglyceride lipase gene. Mol Cell Probes. 1996 Aug;10(4):309–311. doi: 10.1006/mcpr.1996.0040. [DOI] [PubMed] [Google Scholar]
  31. Murtomäki S., Tahvanainen E., Antikainen M., Tiret L., Nicaud V., Jansen H., Ehnholm C. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):1879–1884. doi: 10.1161/01.atv.17.10.1879. [DOI] [PubMed] [Google Scholar]
  32. Oka K., Ishimura-Oka K., Chu M. J., Chan L. Transcription of the human hepatic lipase gene is modulated by multiple negative elements in HepG2 cells. Gene. 1996 Nov 21;180(1-2):69–80. doi: 10.1016/s0378-1119(96)00408-8. [DOI] [PubMed] [Google Scholar]
  33. Semenkovich C. F., Chen S. H., Wims M., Luo C. C., Li W. H., Chan L. Lipoprotein lipase and hepatic lipase mRNA tissue specific expression, developmental regulation, and evolution. J Lipid Res. 1989 Mar;30(3):423–431. [PubMed] [Google Scholar]
  34. Slatkin M., Excoffier L. Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity (Edinb) 1996 Apr;76(Pt 4):377–383. doi: 10.1038/hdy.1996.55. [DOI] [PubMed] [Google Scholar]
  35. Syvänen A. C., Sajantila A., Lukka M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am J Hum Genet. 1993 Jan;52(1):46–59. [PMC free article] [PubMed] [Google Scholar]
  36. Syvänne M., Taskinen M. R., Nieminen, Manninen V., Kesäniemi Y. A., Pasternack A., Nawrocki J. W., Haber H., Frick M. H. A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT Study. Lopid Coronary Angiography Trial. Control Clin Trials. 1997 Feb;18(1):93–119. doi: 10.1016/s0197-2456(96)00091-8. [DOI] [PubMed] [Google Scholar]
  37. Takagi A., Ikeda Y., Mori A., Ashida Y., Yamamoto A. Identification of a BstNI polymorphism in exon 9 of the human hepatic triglyceride lipase gene. Mol Cell Probes. 1996 Aug;10(4):313–314. doi: 10.1006/mcpr.1996.0041. [DOI] [PubMed] [Google Scholar]
  38. Tall A. R. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest. 1990 Aug;86(2):379–384. doi: 10.1172/JCI114722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Verhoeven A. J., Jansen H. Hepatic lipase mRNA is expressed in rat and human steroidogenic organs. Biochim Biophys Acta. 1994 Feb 10;1211(1):121–124. doi: 10.1016/0005-2760(94)90146-5. [DOI] [PubMed] [Google Scholar]
  40. Zambon A., Austin M. A., Brown B. G., Hokanson J. E., Brunzell J. D. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb. 1993 Feb;13(2):147–153. doi: 10.1161/01.atv.13.2.147. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES